Lipids Market Sales to Grow More than Double, Registering 8.7% CAGR through 2032 | Future Market Insights, Inc.
July 21, 2022 07:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, July 21, 2022 (GLOBE NEWSWIRE) -- Future Market Insights (FMI) estimates the global lipids market will witness growth at a CAGR of 8.7% and reach a valuation of US$ 22.5 Bn by 2032....
Lipids Market to Surpass Valuation of US$ 29.9 Bn by 2031, TMR Study
May 19, 2022 12:30 ET
|
Transparency Market Research
Albany NY, United States, May 19, 2022 (GLOBE NEWSWIRE) -- Global market for lipids is making continuous strides from the growing sales of cosmeceuticals, biopharmaceuticals, and nutraceuticals that...
Encapsulation Market Size ($80,071.65Mn by 2028) Driven by Food and Beverages (12.5% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
November 03, 2021 14:46 ET
|
The Insight Partners
New York, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Encapsulation Market: Key InsightsAccording to our new research study on Encapsulation Market Size, Share, Revenue, Forecast to 2028 - COVID-19 Impact and...
Retrotope Reports Data from Phase 2/3 Clinical Trial of RT001 and Concurrent Natural History Study in Patients with Infantile Neuroaxonal Dystrophy (INAD)
October 06, 2021 07:00 ET
|
Retrotope
Treatment with RT001 Results in Statistically Significant Improvements in Overall Survival and Progression Free Survival for INAD Patients as Compared to Control Benefits Supported by Totality of...
Pharmaceutical Lipids Market Is Forecasted To Represent Noteworthy Share During Forecast Period 2021-2028: Acumen Research And Consulting
August 25, 2021 11:09 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, has recently published a report titled “Pharmaceutical Lipids Market – Global Industry Analysis, Market Size,...
Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Progressive Supranuclear Palsy (PSP)
August 11, 2021 07:00 ET
|
Retrotope
LOS ALTOS, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...
Esperion Announces Commercial Availability of NEXLIZET™ (bempedoic acid and ezetimibe) Tablets and Ushers in New Era of Oral Combination Medicine for LDL-Cholesterol Lowering
June 04, 2020 07:00 ET
|
Esperion Therapeutics, Inc.
– First-Ever Non-Statin Combination Medicine, Providing 38 Percent Mean LDL-C Lowering – – Esperion Aims to Set New Industry Standard by Pricing NEXLIZET for Patient Affordability and Access with...
Jojoba oil Market to Reach USD 272.4 Million By 2026 | Reports And Data
April 09, 2019 12:11 ET
|
Reports And Data
Rising cosmetic industry across the globe will boost Market growth. Market Size – USD 187.8 Million in 2018, Market Growth - CAGR of 5.0%, Market Trends – The increasing use of jojoba oil in...
ACC, AHA Release 2018 Guideline on the Management of Blood Cholesterol at AHA Scientific Sessions
November 10, 2018 12:55 ET
|
National Lipid Association
NLA among 12 organizations to co-author, endorse key document for reducing risk of atherosclerotic cardiovascular disease CHICAGO, Nov. 10, 2018 (GLOBE NEWSWIRE) -- The American College of...
PCSK9 Barriers Survey Results Revealed at National Lipid Association Conference
February 07, 2017 09:30 ET
|
National Lipid Association
PHOENIX, AZ--(Marketwired - February 07, 2017) - As part of its Spring Clinical Lipid Update (CLU) in Phoenix, the National Lipid Association (NLA) will reveal the results of its "Challenges in...